Next Article in Journal
Full-Digital Workflow for Fabricating a Custom-Made Direct Metal Laser Sintering (DMLS) Mandibular Implant: A Case Report
Previous Article in Journal
Coronavirus Diseases (COVID-19) Current Status and Future Perspectives: A Narrative Review
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJERPH
Volume 17
Issue 8
10.3390/ijerph17082688
ijerph-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Sexual Dimorphism of Heart Rate Variability in Adolescence: A Case-Control Study on Depression, Anxiety, Stress Levels, Body Composition, and Heart Rate Variability in Adolescents with Impaired Fasting Glucose

by
Charikleia Stefanaki
1,2,*,
Athanasios Michos
1,
George Latsios
3,
Dimitrios Tousoulis
3,
Melpomeni Peppa
4,
Paraskevi Zosi
2,
Dario Boschiero
5 and
Flora Bacopoulou
1
1
Center for Adolescent Medicine and UNESCO Chair on Adolescent Health Care, First Department of Pediatrics, School of Medicine, National and Kapodistrian University of Athens, Aghia Sophia Children’s Hospital, 115 27 Athens, Greece
2
Department of Pediatrics, General Hospital of Nikaia “Agios Panteleimon”, 184 54 Piraeus, Greece
3
First Cardiology Department, School of Medicine, National and Kapodistrian University of Athens, Hippokration Hospital, 115 28 Athens, Greece
4
Endocrine Unit, Second Department of Internal Medicine Propaedeutic, Research Institute and Diabetes Center, Attikon University Hospital, National and Kapodistrian University of Athens, 115 28 Athens, Greece
5
BIOTEKNA Biomedical Technologies, 30020 Venice, Italy
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2020, 17(8), 2688; https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph17082688
Submission received: 7 February 2020 / Revised: 10 April 2020 / Accepted: 11 April 2020 / Published: 14 April 2020
(This article belongs to the Section Health Behavior, Chronic Disease and Health Promotion)
Browse Figures
Versions Notes

Abstract

:
Prediabetes in the form of impaired fasting glucose, impaired glucose tolerance, or both is considered as a preliminary stage for the onset of diabetes and diabetic complications. Hormonal fluctuations in adolescence are accompanied by body composition modifications, which are associated with insulin resistance and subclinical inflammation. Bioimpedance (BIA) accurately evaluates body composition, and heart rate variability (HRV) assesses cardiac autonomic function, which are frequently afflicted by insulin resistance. We aimed at evaluating the effect of glycemic status on mental stress, anxiety, and depression status in adolescents with impaired fasting glucose, body composition, and HRV parameters. This is a case-control study to evaluate the effect of the hyperglycemia on depression, anxiety, and stress levels (DASS21 questionnaire), body composition (BIA-ACC—BIOTEKNA©), and HRV (PPG Stress Flow—BIOTEKNA©), between euglycemic adolescents (euglycemic group) and adolescents with impaired fasting glucose (prediabetic group), aged 12–20 years. No differences were found between the prediabetic (n = 13) and the euglycemic (n = 16) groups in the outcome measures, possibly due to the number of participants. Interestingly, females, irrespective of their glycemic status, exhibited altered sympathovagal function as revealed by impaired HRV. In the euglycemic group, HRV parameters were significantly correlated and in line with the DASS21 scores, but in the prediabetic group, similarities to those of adults were observed. Impaired fasting glucose had no impact on mental health, body composition, or HRV parameters in adolescents. HRV parameters were impaired in females, irrespective of their glycemic status. This finding implies that females seem to be more prone to stress disorders, even from a young age. Future studies are needed to confirm these findings.

1. Introduction

Prediabetes entails a spectrum of subclinical, proinflammatory processes, which include either isolated impaired fasting glucose (IFG), impaired glucose tolerance (IGT), or both (IFG/IGT). Hyperglycemia is linked to disruption of the glucose homeostasis in the skeletal muscles and the liver. When there is dysfunction in these tissues, they generate subclinical proinflammatory processes, which herald the onset of prediabetes complications with different requirements for prevention and treatment if development to full-blown diabetes occurs [1,2].
During adolescence, along with the advancement of sexual maturation, hormonal fluctuations promote lean mass, fat mass, and bone mass increases in different proportions between the sexes, rendering adolescents prone to insulin resistance. The latter seems to play a pivotal, reciprocal role in the observed changes in body composition throughout adolescence [3].
Many studies have demonstrated significant correlations between the hyperactivity of hypothalamic–pituitary–adrenal (HPA) axis, weight gain, and subsequent accumulation of fat tissue [4,5,6]. Thus, overactivation of the stress system appears to contribute to the increase of fat tissue, primarily through upregulation of the HPA axis. Vice versa, increase of fat mass per se seems to constitute a chronic proinflammatory, stressful state that also causes HPA axis imbalance. Additionally, the subclinical inflammation of obesity that contributes to the derangement of the metabolic equilibrium suggests that the proinflammatory cytokines secreted by the adipocytes hold a potentially important pathogenetic role [7]. The proinflammatory molecules, either produced by the adipocytes or by physical and mental stress, contribute to body composition disorders, with detrimental implications in adult health [8] (Figure 1).
Prediabetes is the stage when the diabetic complications begin. There is a significant association between cardiovascular events and IGT, whereas this correlation is less clear in cases of IFG [9,10]. Studies investigating cardiovascular events and cardiac autonomic nervous dysfunction due to prediabetes show controversies, particularly in isolated IFG. It has been stated that altered cardiac autonomic function is present in both IGT and diabetes but not in patients with isolated IFG [11]. The most commonly used methods for the diagnosis of cardiac autonomic function is based on heart rate variability (HRV) assessment, which is the physiological oscillation in the time interval between heartbeats and enables the independent measurement of the parasympathetic and sympathetic components of the autonomic nervous system [12]. Sympatho-adrenal medullary system (SAM) and HPA axis reactivity seem to predict future health and disease outcomes. Exaggerated and blunted responses predict different health and disease outcomes. Reactivity-related health and disease outcomes are both physical and mental. Dysregulation of stress reactivity may represent a mechanism by which psychological stress contributes to the development of future health and disease outcomes [6]. Available data on autonomic nervous system dysfunction in prediabetic adolescents are scarce. The majority of the few studies that evaluate body composition and HRV in prediabetic patients involve adults and they report associations between obesity, proinflammatory metabolic parameters and HbA1c, and autonomic nervous system dysfunction; however, they have no direct relation to prediabetes [13,14].
The aim of this study was to explore the differences between euglycemic adolescents and prediabetic adolescents with IFG in body composition, HRV parameters, and mental aspects along with depression, anxiety, and stress levels.

2. Methods

2.1. Study Design—Setting—Procedures

This case-control study was approved by the National and Kapodistrian University of Athens, Faculty of Medicine Ethics Committee and by the Ethics Committee of the Aghia Sophia Children’s Hospital (repository number: 28931/11.02.2015) and was in accordance with the Helsinki Declaration for human studies [15] and European Medicines Agency Guidelines for Good Clinical Practice. The participants, as well as their legal guardians, gave informed, written consent after explanation of the purpose and the nature of all the procedures used in the study. The privacy rights of human subjects were conserved. The study took place at the Center for Adolescent Medicine (CAM) and United Nations Educational, Scientific and Cultural Organization (UNESCO) Chair on Adolescent Health Care of the First Department of Pediatrics, National and Kapodistrian University of Athens, in Athens, Greece, from March 2015 to January 2016. Study participants were screened for diabetes monthly during each of their three visits. During their last (third) visit, adolescents underwent assessment of their body composition and heart rate variability along with their depression, anxiety, and stress levels, as shown in Figure 2.

2.2. Participants

Adolescent males and females, aged 12–20 years, during their routine visits at the CAM, were evaluated for eligibility to enter the study based on inclusion and exclusion criteria.
Adolescents, defined by a breast Tanner stage equal to III or IV in females, and testicular Tanner stage equal to III or IV in males, were included in the study if they were willing to undergo measurements and intervention procedures and were either euglycemic or prediabetic, based on their serum blood tests and according to the American Diabetes Association (ADA) criteria: a. hemoglobin A1c (Hb1Ac) ranging from 5.7% to 6.4%; and/or b. fasting serum glucose concentrations ranging from 100 to 125 mg/dL.
Exclusion criteria were: a. previous diagnosis of diabetes (established diagnosis of any other type of diabetes); b. treatment with medication that could elevate or normalize blood glucose such as glucocorticosteroids, antidiabetic drugs, or metformin; c. presence of an established diagnosis of cardiovascular disease (congenital, genetic, or otherwise), hypertension, or prehypertension; d. psychiatric disorder; and e. psychiatric disease requiring consultation and/or pharmacologic treatment. After written consent was obtained, study participants were assessed at baseline and at two sequential monthly visits to the CAM.
Baseline demographic characteristics included: age, biological sex, weight, height, body mass index (BMI) z-score, presence of positive family history for diabetes, i.e., first- or second-degree relatives with diabetes, and single-parent family structure, i.e., divorced, separated, or widowed legal guardians.

2.3. Measurements

2.3.1. Diabetes Screening

Blood was drawn from each participant in the morning at 8 a.m., after a 10-h overnight fast. During the visits, adolescents would not be subject to intercurrent illness, recent accident, or extremely stressful events. Blood samples were collected for measurement of serum glucose on each of the three visits (1st, 2nd, 3rd), whereas HbA1c was measured only on the 1st visit.

2.3.2. Body Composition Analysis

Body composition analysis was conducted via bioimpedance (BIA), using the BIA-ACC device (BIOTEKNA©, Biomedical Technologies, Venice, Italy), which has been validated against dual-energy X-ray absorptiometry (DXA) [16,17,18]. Measurements were performed according to the manufacturer’s guidelines, during the 3rd visit, between 8:15 and 8:30 a.m., after an overnight fast, and bladder voiding. Adolescents should not have performed any exercise before measurements. This device applies alternating currents, using two different frequencies, 50 and 1.5 kHz (bi-frequency measurement method), to compute body composition, based on a multicompartment model (2C, 3C, 4C, 5C). Assessment was performed with each participant lying supine on a flat, nonconducting surface, with no contact with metallic elements. Two electrodes were applied on the dorsal surface of the right hand and two electrodes on the dorsal surface of the right foot.
The formulas used for computations have been previously described in detail [18]. For each adolescent, the following body composition parameters were estimated: total body water in Lt and % of total body weight; intracellular body water in Lt and % of total body water; extracellular body water in Lt and % of total body water; fat-free mass in kg, and body weight %; fat mass in kg and body weight %; skeletal muscle mass in kg and fat-free mass %; abdominal adipose tissue in cm2; and intramuscular adipose tissue in kg and body weight %. The results were shown in the BioTekna Plus software platform on a local personal computer (PC).

2.3.3. Heart Rate Variability Assessment

Heart rate variability (HRV) was assessed with the use of a photo-plethysmographic (PPG) stress flow device, based on a multi-channel plethysmographic technology applied to the distal ends of the limbs that allows analysis of the overall activity of the autonomic nervous system and of the HRV. The HRV test has a duration of 5 min and allows monitoring of the functionality of the autonomic nervous system and assists in the differential diagnosis of chronic inflammatory and stress-related disorders [19].
Measurements were performed according to the manufacturer’s guidelines during the 3rd visit between 8:00 and 8:15 a.m., for all study participants, to assess average heart rate (mean HR), time domain parameters, such as standard deviation of all normal-to-normal (NN) intervals (SDNN); square root of the mean of the sum of the squares of differences between adjacent NN intervals (RMSSD) and frequency domain parameters, such as power in very low frequency range 0.04 Hz (VLF power) as prefrontal cortex (PFC) activity indicator; power in low frequency range 0.04–0.15 Hz (LF power) as sympathetic activity indicator; power in high frequency range 0.15–0.4 Hz (HF power) as parasympathetic activity indicator; and HRV representation (scatter-heart rate) and bilateral flow bloodstream multi-channel representation {LF (in ms2)/HF (ms2) ratio}. The results were shown in the BioTekna Plus software platform on a local PC [12,20].

2.3.4. DASS21 (Depression, Anxiety, Stress Scales) Questionnaire

The DASS21 comprises a set of three self-reported scales, designed to measure the perception/physical symptomatology of the negative emotional states of depression, anxiety, and stress, during the past week. It includes 21 items, divided into subscales of seven items each; the depression subscale (items 3, 5, 10, 13, 16, 17, and 21), the anxiety subscale (items 2, 4, 7, 9, 15, 19, and 20), and the stress subscale (items 1, 6, 8, 11, 12, 14, and 18). The questionnaire, validated in Greek [21], was given to all study participants. All responses were ranked on a four-point Likert scale, ranging from 0 (“did not apply to me—never”) to 3 (“applied to me very much or most of the time—almost always”).

2.4. Statistical Methods

Statistical significance was set at p < 0.05. All data analyses were performed using the SPSS v.21 statistical software (IBM Co., New York, NY, USA). Baseline descriptive characteristics are represented as median values, range, and quartiles for continuous variables and absolute and proportional values (%) for categorical variables. Mann–Whitney U tests were employed for the evaluation of the statistical differences between prediabetic and euglycemic adolescents, as well as between males and females. Pearson’s chi square tests were employed for the frequency group comparisons. Spearman’s rho tests were performed for the evaluation of the variables under study. Cronbach alpha coefficient analyses were performed for every DASS21 subscale, to assess internal consistency.

2.5. Sample Size Calculations

We aimed at 12–25 subjects per group as this was a pilot study [22].

3. Results

3.1. Study Sample

Initially, a total of 80 adolescents, who attended the Center for Adolescent Medicine and UNESCO Chair on Adolescent Health Care over the three-month recruitment period, were deemed eligible to enter the study. Fifty-one adolescents were subsequently excluded and finally 29 adolescents were included in the study; 16 euglycemic (euglycemic group) and 13 prediabetic (prediabetic group) who were found to have IFG for 3 consequent months (Figure 2).
No statistically significant differences in the baseline psychometric and demographic characteristics were found between the two groups, except for the three subsequent measurements of serum glucose concentrations (Table 1). The Cronbach alpha coefficients for DASS21 Subscales internal consistency proved to be extremely reliable (DASS21 Stress: 0.881; DASS21 Anxiety: 0.862; and DASS21 Depression: 0.883). According to the DASS manual, the participants of both groups did not exhibit severe or extremely severe clinical depression, anxiety, or stress [23].

3.2. Body Composition Analysis and Heart Rate Variability

No statistically significant differences were found in the body composition parameters or the HRV parameters between the prediabetic and the euglycemic group (Table 2).
However, statistically significant differences were detected in the time and frequency domain parameters of the HRV between males and females, irrespective of the glycemic state. More specifically, the SDNN, RMSSD, and HF power (Figure 3) were decreased in females vs. males ((Median = 75 vs. 113; 48 vs. 106.5; 6.81 vs. 8.27, respectively); Mean Rank = 7.82 vs. 15.83; U = 20; p = 0.004/Mean Rank = 8.36 vs. 15.33; U = 26; p = 0.013;/Mean Rank = 8.55 vs. 15.17; U = 23; p = 0.007, respectively), whereas the LF/HF ratio (Figure 3) was increased in females vs. males ((Median = 1.6 vs. 0.65, respectively); Mean Rank = 15.45 vs. 8.83, U = 28; p = 0.019).
No statistically significant differences between males vs. females were found for any other study variables.

3.3. Additional Analyses

Analysis of the total sample did not yield any statistically significant correlations; however, when the two groups were analyzed separately, statistically significant correlations were found between several HRV parameters and the scores of DASS21 subscales.
In the euglycemic group, both the DASS21 Depression and Anxiety subscale scores were negatively correlated with LF/HF log (Spearman’s rho = −0.879, p = 0.009; Spearman’s rho = −0.781, p = 0.038, respectively); LF/HF ratio (Spearman’s rho = −0.879, p = 0.009; Spearman’s rho = −0.781, p = 0.038, respectively); LF % (Spearman’s rho = −0.919, p = 0.003; Spearman’s rho = −0.863, p = 0.012, respectively); and were positively correlated with HF % (Spearman’s rho = 0.919, p = 0.003; Spearman’s rho = 0.863, p = 0.012, respectively).
In the prediabetic group, the DASS21 Stress subscale score was negatively correlated with RMSSD (Spearman’s rho = −0.805, p = 0.002); VLF (Spearman’s rho = −0.654, p = 0.021); LF % (Spearman’s rho = −0.777, p = 0.003); and HF % (Spearman’s rho = 0.787, p = 0.002). The DASS21 Anxiety subscale score was negatively correlated with SDNN (Spearman’s rho = −0.585, p = 0.046); HF % (Spearman’s rho = −0.609, p = 0.036); and positively correlated with LF/HF log (Spearman’s rho = 0.641, p = 0.025); LF/HF ratio (Spearman’s rho = 0.602, p = 0.038); LF % (Spearman’s rho = 0.63, p = 0.028); and HF % (Spearman’s rho = −0.63, p = 0.028). In the same group, the DASS21 Depression subscale score was negatively associated with SDNN (Spearman’s rho = −0.585, p = 0.046).

4. Discussion

In this study, we examined the differences between euglycemic and prediabetic adolescents in their body composition and HRV, with concurrent evaluation of their depression, anxiety, and stress levels. No differences were found between the euglycemic and the prediabetic group, whereas female sex seemed to have an impact on HRV, irrespective of the glycemic status. Additionally, statistically significant associations were revealed between time and frequency domains of the HRV and the subscales of the DASS21 questionnaire in the euglycemic and prediabetic participants separately. To our knowledge, this is the first study to examine depression, anxiety, and stress levels in relation to body composition and HRV in prediabetic vs. euglycemic adolescents.
Numerous studies have found that prediabetes is strongly associated with increased weight and BMI [24,25]. Other studies report emotional stress and emotional eating, leading to disruptive behaviors that are linked to increased weight, BMI [26,27], abnormal metabolic profiles, and inflammatory body composition phenotypes [3,8,18]. Interestingly, such conclusions cannot be drawn from the demographic, psychometric, and body composition profile of our study sample. Although the prediabetic group, in relation with the euglycemic group, was overweight—though not to a statistically significant degree—body composition parameters did not differ significantly between the two groups.
Prediabetes is a stage where most of the macro- and micro-vascular lesions exhibit their insidious onset. One of the most dangerous and frequent complications is autonomic neuropathy. One facet of diabetic autonomic neuropathy is the cardiac autonomic neuropathy, as a result of profuse subclinical inflammatory processes that are also present in hyperglycemia [28]. Heart rate variability is a measure of sympathovagal imbalance, and it has been long used for the evaluation of the function of autonomic nervous system, either for research purposes or in the clinical setting [29].
One recent study demonstrated the effectiveness of HRV in conjunction with salivary cortisol in assessing stress levels. They claimed that the robustness of this method renders it a potential indication of future health [30]. Another study indicated that reduced HRV with higher psychological distress and increased salivary cortisol levels were observed in patients with temporomandibular disorders [31,32]. Another finding of the present study was the lack of significant differences between the two groups in the time and frequency domain parameters of the HRV, and this is in agreement with the results of Lee et al. in a study of a large number of obese prediabetic adolescents that are similar to ours [33]. Additionally, Asghar et al. demonstrated normal cardiac sympathetic innervation in prediabetic adults [34], a finding that reinforces our findings. The inflammatory processes, caused in the prediabetic state, may need to persist in time before producing clinically significant signs of cardiac autonomic neuropathy that may be detectable with an HRV test. Additionally, a surge of growth hormone is observed in adolescence. Growth hormone is responsible for the growth spurt but it also exhibits antioxidant properties [35] that possibly, even if it provokes insulin resistance [36], counterbalances the pro-oxidative processes of hyperglycemia [37]. Regrettably, no such studies exist in adolescents. However, heart rate variability is abnormal in adult patients with growth hormone deficiency. The impaired sympathetic tone could be a consequence of reduced central sympathetic tone or altered cardiac responsiveness to autonomic control and may contribute to the increased cardiovascular risk in those patients [38].
There seem to be biological sex differences in the hypothalamic-pituitary-adrenal (HPA) axis response in the normal physiology of the stress autonomic response, and thus in HRV results [39], due to gonadal steroids [40]. The release of cortisol differs between the sexes, particularly following stress events. Cortisol increases are higher and remain elevated for longer in females [41]. Both estrogen and testosterone temper with cortisol concentrations, and thus, the degree of HPA axis activation is also dependable on both of these hormones, suggesting an interaction between the HPA and the hypothalamic-pituitary-gonadal (HPG) axes. In addition to explaining the slightly increased, basal and stress-stimulated HPA axis function in the female sex, the estrogen-induced enhancement of the cortisol releasing hormone (CRH) neuron may also help explain the paradox of negative estrogen feedback effect on the hypothalamic gonadotropin-releasing hormone (GnRH) neuron, which, unlike the paraventricular nucleus, lacks estrogen receptors [42]. Conclusively, gonadal steroids impact HPA axis reactivity differentially. Gonadectomy of male rats elevates, while androgen replacement blunts the cortisol and adrenocorticotrophic hormone (ACTH) response to stress [43]. In contrast, ovariectomy reduces, while estradiol treatment increases, the gain of the HPA axis [44]. Interestingly, one study demonstrated that females when stressed presented with variants that did not differ on aggression, and secondary variants showed higher cortisol, testosterone, cortisol-to-dehydroepiandrosterone (DHEA) ratios, and HRV. These findings suggested that the neurobiological mechanisms underpinning aggression and thus, stress response may differ between women on primary versus secondary developmental pathways [31].
Our results suggested sexual dimorphism in the HRV tests. Females seemed to have an upregulated HPA axis, probably due to the rise of sex hormones, such as estrogens and progesterone [45]. Nevertheless, they did not exhibit statistically significant differences in any other study variables, such as the DASS21 subscales. In line with our results are the findings of the meta-analysis of Koenig and Thayer on biological sex differences in HRV [46]. These authors found that females showed less variability within the time-series of heartbeats indexed by SDNN and lower total power in the spectral density, probably due to a greater mean heart rate (HR) reflected by a smaller mean R-to-R (RR) interval.
Moreover, profound anatomic brain reorganization processes also take place in adolescence; part of these processes is known as “neural pruning”. The maturation of the reproductive system is accompanied by rising concentrations of the gonadal steroids. The human brain has a high density of steroid receptors, and the sex steroids exert various effects on neural networks during adolescence [47,48]. According to this model, sex steroids affect the development of the adolescent brain by sensitizing neural networks that result in a permanent reorganization of the brain. Sex steroids have different effects on the developing HPA axis in males and females: the rise of androgens in males inhibits the hypothalamic secretion of corticotropin-releasing hormone (CRH), while estrogens in females upregulate the HPA axis. Therefore, estrogens render females more susceptible to stress and stress disorders, while androgens make males more resilient to it [49], due to the estrogen response element in the glucocorticoid receptors [50]. Another aspect that should be considered is the developing heart of the adolescents and the existence of heart volume between males and females [51].
On a different note, interesting correlations between the HRV parameters and the psychometric subscales of DASS21 were revealed. HRV has been subject to criticism [52], since there are no clear boundaries between the two branches of the autonomic nervous system, due to their dynamic balance, especially in developing brains [53]. Normal, healthy adolescent brains give rise to odd results in the HRV tests. A significant number of studies that evaluated HRV parameters in adolescents concluded that these unusual findings may be attributed to changes in the prefrontal cortex and limbic system connections that transpire across adolescence [54].
Given the coupling of central and autonomic nervous system functioning in the regulation of the stress response, the decrease in vagotonic activity across adolescence may be driven, at least partially, by the central nervous system, as well as by the maturation of the sympathetic nervous system [55]. The DASS21 scores of anxiety in the euglycemic group seemed to decrease when the activity of the sympathetic nervous system increased. The results of the frequency domain of the HRV in the euglycemic group reflect the aforementioned findings. On the contrary, in the prediabetic group, the results were similar to those of adults. More specifically, when the function of the sympathetic nervous system was augmented, or when the sympathovagal balance was dysregulated, the stress, anxiety, and depression levels were also augmented. Whether this is due to maturity of the prefrontal cortex or IFG remains to be elucidated. Possibly, a combined approach of the activity of the LF and HF bands in HRV tests would result in more accurate interpretation of mental and physical stress, especially in periods of increased risk for the onset of emotional disorders, such as adolescence [56,57,58], and this is one limitation of this study. The small number of subjects in this study represents another limitation in this study.

5. Conclusions

Conclusively, impaired fasting glycemia seems to have no impact on body composition, mental health, or HRV; the participants of both groups had similar mental health scores, evaluated by the DASS21 questionnaire; body composition, evaluated by the BIA-ACC device; and HRV parameters, evaluated by PPG-Stress Flow. Adolescent females seem to have an upregulated HPA axis, as the values of HRV parameters were abnormal when compared with their male counterparts, independently of hyperglycemia. Thus, females seem to be more prone to stress-related disorders from a young age, but there are still a lot of missing parameters to be further evaluated to have definite conclusions. Any firm conclusions cannot be drawn from this study. Future, more sophisticated studies of larger numbers of prediabetic adolescents are needed to confirm these findings.

Author Contributions

All authors contributed equally in this study and according to the rules of ICMJE. C.S. conceived the original idea of the study, analyzed the data, reviewed, wrote the manuscript and approved the final version of all data. A.M., P.Z., and F.B. contributed to the recruitment, supervised the study procedures, and reviewed the manuscript. G.L., D.T., M.P., and D.B. contributed to the original idea of the study and reviewed the manuscript. All authors read and approved the final manuscript.

Funding

BioTekna Biomedical Technologies, Venice, Italy provided the devices (BIA-ACC & PPG Stress Flow) for the study. This study did not receive any financial resources from any public or private sector.

Acknowledgments

The authors would like to thank G.P. Chrousos for his constant support and counseling in this study. Availability of Data and Materials: The data that support the findings of this study are openly available in the OSF repository @ https://osf.io/guqcz/?view_only=3306d59464d24745a3b21e62c65719b3 doi:10.17605/OSF.IO/GUQCZ.

Conflicts of Interest

C.S., A.M., G.L., D.T., M.P., P.Z. and F.B. declare no competing interest. D.B. is the scientific director of BIOTEKNA, Biomedical Technologies, Venice, Italy.

Abbreviations

ADAAmerican Diabetes Association
BIABio-impedance analysis
BMIBody mass index
CAMCenter for Adolescent Medicine
CRHCorticotropin-releasing hormone
DASS21Depression, anxiety, stress scales 21
DXADual-energy X-ray absorptiometry
HRVHeart rate variability
Hb1AcHemoglobin A1c
IFGImpaired fasting glycemia
IGTImpaired glucose tolerance
HRHeart rate
HFHigh frequency
HPAHypothalamic-pituitary-adrenal axis
LFLow frequency
PFCPrefrontal Cortex
SAMSympatho-adrenal medullary system
T1DMType 1 diabetes
T2DMType 2 diabetes
RMSSDSquare root of the mean of the sum of the squares of differences between adjacent Normal to Normal intervals
SDNNStandard deviation of all Normal to Normal intervals
VLFVery low frequency

References

  1. Faerch, K.; Borch-Johnsen, K.; Holst, J.J.; Vaag, A. Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: Does it matter for prevention and treatment of type 2 diabetes? Diabetologia 2009, 52, 1714–1723. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Meyer, C.; Pimenta, W.; Woerle, H.J.; Van Haeften, T.; Szoke, E.; Mitrakou, A.; Gerich, J. Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care 2006, 29, 1909–1914. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Stefanaki, C.; Bacopoulou, F.; Peppa, M. Prediabetes and adolescence—Trends, causes, effects, and screening. US Endocrinol. 2016, 12, 94–98. [Google Scholar] [CrossRef] [Green Version]
  4. Lucassen, E.A.; Cizza, G. The hypothalamic-pituitary-adrenal axis, obesity, and chronic stress exposure: Sleep and the HPA axis in obesity. Curr. Obes. Rep. 2012, 1, 208–215. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Hillman, J.B.; Dorn, L.D.; Loucks, T.L.; Berga, S.L. Obesity and the hypothalamic-pituitary-adrenal axis in adolescent girls. Metabolism 2012, 61, 341–348. [Google Scholar] [CrossRef] [Green Version]
  6. Turner, A.I.; Smyth, N.; Hall, S.J.; Torres, S.J.; Hussein, M.; Jayasinghe, S.U.; Ball, K.; Clow, A.J. Psychological stress reactivity and future health and disease outcomes: A systematic review of prospective evidence. Psychoneuroendocrinology 2020, 114, 104599. [Google Scholar] [CrossRef]
  7. Kyrou, I.; Chrousos, G.P.; Tsigos, C. Stress, visceral obesity, and metabolic complications. Ann. N. Y. Acad. Sci. 2006, 1083, 77–110. [Google Scholar] [CrossRef]
  8. Stefanaki, C.; Pervanidou, P.; Boschiero, D.; Chrousos, G.P. Chronic stress and body composition disorders: Implications for health and disease. Hormones 2018, 17, 33–43. [Google Scholar] [CrossRef] [Green Version]
  9. Temelkova-Kurktschiev, T.S.; Koehler, C.; Henkel, E.; Leonhardt, W.; Fuecker, K.; Hanefeld, M. Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care 2000, 23, 1830–1834. [Google Scholar] [CrossRef] [Green Version]
  10. Carnevale Schianca, G.P.; Rossi, A.; Sainaghi, P.P.; Maduli, E.; Bartoli, E. The significance of impaired fasting glucose versus impaired glucose tolerance: Importance of insulin secretion and resistance. Diabetes Care 2003, 26, 1333–1337. [Google Scholar] [CrossRef] [Green Version]
  11. Wu, J.S.; Yang, Y.C.; Lin, T.S.; Huang, Y.H.; Chen, J.J.; Lu, F.H.; Wu, C.H.; Chang, C.J. Epidemiological evidence of altered cardiac autonomic function in subjects with impaired glucose tolerance but not isolated impaired fasting glucose. J. Clin. Endocrinol. Metab. 2007, 92, 3885–3889. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Shaffer, F.; Ginsberg, J.P. An overview of heart rate variability metrics and norms. Front. Public Health 2017, 5, 258. [Google Scholar] [CrossRef] [Green Version]
  13. Dimova, R.; Tankova, T.; Chakarova, N.; Groseva, G.; Dakovska, L. Cardiovascular autonomic tone relation to metabolic parameters and hsCRP in normoglycemia and prediabetes. Diabetes Res. Clin. Pract. 2015, 109, 262–270. [Google Scholar] [CrossRef] [PubMed]
  14. Elming, M.B.; Hornum, M.; Feldt-Rasmussen, B.; Mathiesen, E.R. Cardiac autonomic neuropathy in patients with uraemia is not related to pre-diabetes. Dan. Med. Bull. 2011, 58, A4244. [Google Scholar] [PubMed]
  15. Assembly, T.W.G. WMA Declaration of Helsinki—Ethical Principles for Medical Research Involving Human Subjects. Available online: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/ (accessed on 14 April 2020).
  16. Peppa, M.; Stefanaki, C.; Papaefstathiou, A.; Boschiero, D.; Dimitriadis, G.; Chrousos, G.P. Bioimpedance analysis vs. DEXA as a screening tool for osteosarcopenia in lean, overweight and obese Caucasian postmenopausal females. Hormones (Athens) 2017, 16, 181–193. [Google Scholar] [PubMed] [Green Version]
  17. Straub, R.H.; Ehrenstein, B.; Gunther, F.; Rauch, L.; Trendafilova, N.; Boschiero, D.; Grifka, J.; Fleck, M. Increased extracellular water measured by bioimpedance and by increased serum levels of atrial natriuretic peptide in RA patients-signs of volume overload. Clin. Rheumatol. 2017, 36, 1041–1051. [Google Scholar] [CrossRef] [PubMed]
  18. Tsigos, C.; Stefanaki, C.; Lambrou, G.I.; Boschiero, D.; Chrousos, G.P. Stress and inflammatory biomarkers and symptoms are associated with bioimpedance measures. Eur. J. Clin. Investig. 2015, 45, 126–134. [Google Scholar] [CrossRef]
  19. Rohling, M.; Strom, A.; Bonhof, G.; Puttgen, S.; Bodis, K.; Mussig, K.; Szendrodi, J.; Markgraf, D.; Lehr, S.; Roden, M.; et al. Differential patterns of impaired cardiorespiratory fitness and cardiac autonomic dysfunction in recently diagnosed type 1 and type 2 diabetes. Diabetes Care 2017, 40, 246–252. [Google Scholar] [CrossRef] [Green Version]
  20. Heart rate variability: Standards of measurement, physiological interpretation and clinical use. Task force of the European society of cardiology and the North American society of pacing and electrophysiology. Circulation 1996, 93, 1043–1065.
  21. Lyrakos, G.; Arvaniti, C.; Smyrnioti, M.; Kostopanagiotou, G. Translation and validation study of the depression anxiety stress scale in the Greek general population and in a psychiatric patient’s sample. Eur. Psychiatry 2011, 26, 1731. [Google Scholar] [CrossRef]
  22. Julious, S. Sample size of 12 per group rule of thumb for a pilot study. Pharm. Stat. 2005, 4, 287–291. [Google Scholar] [CrossRef]
  23. Lovibond, S.H.; Lovibond, P.F. Manual for the Depression Anxiety & Stress Scales, 2nd ed.; Psychology Foundation: Sydney, Australia, 1992. [Google Scholar]
  24. Colip, L.; Burge, M.R.; Sandy, P.; Ghahate, D.; Bobelu, J.; Faber, T.; Shah, V. Exercise intervention improves the metabolic profile and body composition of Southwestern American Indian adolescents. J. Diabetes Obes. 2016, 3. [Google Scholar] [CrossRef]
  25. Garnett, S.P.; Gow, M.; Ho, M.; Baur, L.A.; Noakes, M.; Woodhead, H.J.; Broderick, C.R.; Chisholm, K.; Briody, J.; De, S.; et al. Improved insulin sensitivity and body composition, irrespective of macronutrient intake, after a 12 month intervention in adolescents with pre-diabetes; RESIST a randomised control trial. BMC Pediatr. 2014, 14, 289. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Vanaelst, B.; Michels, N.; Clays, E.; Herrmann, D.; Huybrechts, I.; Sioen, I.; Vyncke, K.; De Henauw, S. The association between childhood stress and body composition, and the role of stress-related lifestyle factors--cross-sectional findings from the baseline ChiBSD survey. Int. J. Behav. Med. 2014, 21, 292–301. [Google Scholar] [CrossRef]
  27. Bacopoulou, F.; Foskolos, E.; Stefanaki, C.; Tsitsami, E.; Vousoura, E. Disordered eating attitudes and emotional/behavioral adjustment in Greek adolescents. Eat. Weight Disord. EWD 2018, 23, 621–628. [Google Scholar] [CrossRef]
  28. Waqar, F.; Gerson, M.C. Cardiac sympathetic imaging in the diagnosis of cardiac autonomic neuropathy in pre-diabetes. J. Nucl. Cardiol. Off. Publ. Am. Soc. Nucl. Cardiol. 2015, 22, 1269–1272. [Google Scholar] [CrossRef] [Green Version]
  29. Thayer, J.F.; Sternberg, E. Beyond heart rate variability: Vagal regulation of allostatic systems. Ann. N. Y. Acad. Sci. 2006, 1088, 361–372. [Google Scholar] [CrossRef]
  30. Aimie-Salleh, N.; Malarvili, M.B.; Whittaker, A.C. Fusion of heart rate variability and salivary cortisol for stress response identification based on adverse childhood experience. Med. Biol. Eng. Comput. 2019, 57, 1229–1245. [Google Scholar] [CrossRef]
  31. Goulter, N.; Kimonis, E.R.; Denson, T.F.; Begg, D.P. Female primary and secondary psychopathic variants show distinct endocrine and psychophysiological profiles. Psychoneuroendocrinology 2019, 104, 7–17. [Google Scholar] [CrossRef]
  32. Chinthakanan, S.; Laosuwan, K.; Boonyawong, P.; Kumfu, S.; Chattipakorn, N.; Chattipakorn, S.C. Reduced heart rate variability and increased saliva cortisol in patients with TMD. Arch. Oral Biol. 2018, 90, 125–129. [Google Scholar] [CrossRef]
  33. Lee, S.; Cowan, P.A.; Wetzel, G.T.; Velasquez-Mieyer, P. Prediabetes and blood pressure effects on heart rate variability, QT-interval duration, and left ventricular hypertrophy in overweight-obese adolescents. J. Pediatr. Nurs. 2011, 26, 416–427. [Google Scholar] [CrossRef] [PubMed]
  34. Asghar, O.; Arumugam, P.; Armstrong, I.S.; Ray, S.G.; Schmitt, M.; Malik, R.A. Individuals with impaired glucose tolerance demonstrate normal cardiac sympathetic innervation using I-123 mIBG scintigraphy. J. Nucl. Cardiol. Off. Publ. Am. Soc. Nucl. Cardiol. 2015, 22, 1262–1268. [Google Scholar] [CrossRef] [PubMed]
  35. Paltoglou, G.; Fatouros, I.G.; Valsamakis, G.; Schoina, M.; Avloniti, A.; Chatzinikolaou, A.; Kambas, A.; Draganidis, D.; Mantzou, A.; Papagianni, M.; et al. Antioxidation improves in puberty in normal weight and obese boys, in positive association with exercise-stimulated growth hormone secretion. Pediatr. Res. 2015, 78, 158–164. [Google Scholar] [CrossRef] [Green Version]
  36. Kim, S.H.; Park, M.J. Effects of growth hormone on glucose metabolism and insulin resistance in human. Ann. Pediatr. Endocrinol. Metab. 2017, 22, 145–152. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Pankratova, M.S.; Baizhumanov, A.A.; Yusipovich, A.I.; Faassen, M.; Shiryaeva, T.Y.; Peterkova, V.A.; Kovalenko, S.S.; Kazakova, T.A.; Maksimov, G.V. Imbalance in the blood antioxidant system in growth hormone-deficient children before and after 1 year of recombinant growth hormone therapy. PeerJ 2015, 3, e1055. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  38. Leong, K.S.; Mann, P.; Wallymahmed, M.; MacFarlane, I.A.; Wilding, J.P. Abnormal heart rate variability in adults with growth hormone deficiency. J. Clin. Endocrinol. Metab. 2000, 85, 628–633. [Google Scholar] [CrossRef] [PubMed]
  39. Pothineni, N.V.; Shirazi, L.F.; Mehta, J.L. Gender differences in autonomic control of the cardiovascular system. Curr. Pharm. Des. 2016, 22, 3829–3834. [Google Scholar] [CrossRef] [PubMed]
  40. Oyola, M.G.; Handa, R.J. Hypothalamic-pituitary-adrenal and hypothalamic-pituitary-gonadal axes: Sex differences in regulation of stress responsivity. Stress 2017, 20, 476–494. [Google Scholar] [CrossRef]
  41. Goel, N.; Workman, J.L.; Lee, T.T.; Innala, L.; Viau, V. Sex differences in the HPA axis. Compr. Physiol. 2014, 4, 1121–1155. [Google Scholar]
  42. Vamvakopoulos, N.C.; Chrousos, G.P. Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression. Potential implications for the sexual dimophism of the stress response and immune/inflammatory reaction. J. Clin. Investig. 1993, 92, 1896–1902. [Google Scholar] [CrossRef]
  43. Handa, R.J.; Burgess, L.H.; Kerr, J.E.; O’Keefe, J.A. Gonadal steroid hormone receptors and sex differences in the hypothalamo-pituitary-adrenal axis. Horm. Behav. 1994, 28, 464–476. [Google Scholar] [CrossRef] [PubMed]
  44. Lund, T.D.; Munson, D.J.; Haldy, M.E.; Handa, R.J. Androgen inhibits, while oestrogen enhances, restraint-induced activation of neuropeptide neurones in the paraventricular nucleus of the hypothalamus. J. Neuroendocrinol. 2004, 16, 272–278. [Google Scholar] [CrossRef] [PubMed]
  45. Koenig, J.; Rash, J.A.; Campbell, T.S.; Thayer, J.F.; Kaess, M. A meta-analysis on sex differences in resting-state vagal activity in children and adolescents. Front. Physiol. 2017, 8, 582. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Koenig, J.; Thayer, J.F. Sex differences in healthy human heart rate variability: A meta-analysis. Neurosci. Biobehav. Rev. 2016, 64, 288–310. [Google Scholar] [CrossRef]
  47. Vigil, P.; Orellana, R.F.; Cortes, M.E.; Molina, C.T.; Switzer, B.E.; Klaus, H. Endocrine modulation of the adolescent brain: A review. J. Pediatr. Adolesc. Gynecol. 2011, 24, 330–337. [Google Scholar] [CrossRef] [PubMed]
  48. Schwarz, J.M.; Liang, S.L.; Thompson, S.M.; McCarthy, M.M. Estradiol induces hypothalamic dendritic spines by enhancing glutamate release: A mechanism for organizational sex differences. Neuron 2008, 58, 584–598. [Google Scholar] [CrossRef] [Green Version]
  49. Naninck, E.F.; Lucassen, P.J.; Bakker, J. Sex differences in adolescent depression: Do sex hormones determine vulnerability? J. Neuroendocrinol. 2011, 23, 383–392. [Google Scholar] [CrossRef]
  50. Vamvakopoulos, N.C.; Chrousos, G.P. Hormonal regulation of human corticotropin-releasing hormone gene expression: Implications for the stress response and immune/inflammatory reaction. Endocr. Rev. 1994, 15, 409–420. [Google Scholar] [CrossRef]
  51. Perrichon, P.; Grosell, M.; Burggren, W.W. Heart performance determination by visualization in larval fishes: Influence of alternative models for heart shape and volume. Front. Physiol. 2017, 8, 464. [Google Scholar] [CrossRef] [Green Version]
  52. Arza, A.; Garzon, J.M.; Hemando, A.; Aguilo, J.; Bailon, R. Towards an objective measurement of emotional stress: Preliminary analysis based on heart rate variability. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2015, 2015, 3331–3334. [Google Scholar]
  53. Bush, N.R.; Caron, Z.K.; Blackburn, K.S.; Alkon, A. Measuring cardiac autonomic nervous system (ANS) activity in toddlers—Resting and developmental challenges. J. Vis. Exp. 2016. [Google Scholar] [CrossRef] [PubMed]
  54. Hollenstein, T.; McNeely, A.; Eastabrook, J.; Mackey, A.; Flynn, J. Sympathetic and parasympathetic responses to social stress across adolescence. Dev. Psychobiol. 2012, 54, 207–214. [Google Scholar] [CrossRef]
  55. Hamilton, J.L.; Alloy, L.B. Atypical reactivity of heart rate variability to stress and depression across development: Systematic review of the literature and directions for future research. Clin. Psychol. Rev. 2016, 50, 67–79. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  56. Stringaris, A.; Castellanos-Ryan, N.; Banaschewski, T.; Barker, G.J.; Bokde, A.L.; Bromberg, U.; Buchel, C.; Fauth-Buhler, M.; Flor, H.; Frouin, V.; et al. Dimensions of manic symptoms in youth: Psychosocial impairment and cognitive performance in the IMAGEN sample. J. Child Psychol. Psychiatry 2014, 55, 1380–1389. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  57. Vulser, H.; Lemaitre, H.; Artiges, E.; Miranda, R.; Penttila, J.; Struve, M.; Fadai, T.; Kappel, V.; Grimmer, Y.; Goodman, R.; et al. Subthreshold depression and regional brain volumes in young community adolescents. J. Am. Acad. Child Adolesc. Psychiatry 2015, 54, 832–840. [Google Scholar] [CrossRef]
  58. Maughan, B.; Collishaw, S.; Stringaris, A. Depression in childhood and adolescence. J. Can. Acad. Child Adolesc. Psychiatry 2013, 22, 35–40. [Google Scholar]
Ijerph 17 02688 g001 550
Figure 1. Concept of the study.
Figure 1. Concept of the study.
Ijerph 17 02688 g001
Ijerph 17 02688 g002 550
Figure 2. Participants’ flow chart and study procedure.
Figure 2. Participants’ flow chart and study procedure.
Ijerph 17 02688 g002
Ijerph 17 02688 g003 550
Figure 3. Statistically significant differences in heart rate variability (HRV) parameters between the biological sexes.
Figure 3. Statistically significant differences in heart rate variability (HRV) parameters between the biological sexes.
Ijerph 17 02688 g003
Table
Table 1. Characteristics of the study sample.
Table 1. Characteristics of the study sample.
VariablesEuglycemic Group
IQR
(n = 16)		Prediabetic Group
IQR
(n = 13)		p
Age (years)14.5 (12.5–15.75)15 (15–16.5)0.17
Male sex6 (37.5%)7 (53.8%)0.379
Weight Z-score0.68 (0.05–2.17)2.07 (−0.03–2.3)0.2
Height Z-score0 (−0.14–0.93)0.6 (0.05–1.75)0.13
BMI Z-score0.7 (−0.1–1.9)1.76 (0.05–2.15)0.3
1st visit FBG (mg/dL)92 (83.5–97)105 (102–111)0.003
2nd visit FBG (mg/dL)93 (87.2–96.7)110 (105–118)<0.001
3rd visit FBG (mg/dL)91 (80.5–99)104 (101.5–108)0.001
HbA1c (%)5 (4.85–5.3)5.2 (5–5.2)0.252
Positive family history of diabetes10 (62.5%)10 (76.9%)0.54
Single-parent family3 (18.8%)3 (32.1%)0.775
DASS 21 Stress Subscale13 (3–23.5)15 (6.5–19.5)0.77
DASS 21 Anxiety Subscale12 (0.5–19)8 (2.5–14)0.6
DASS 21 Depression Subscale10 (1–20)10 (2.5–15.5)0.86
Abbreviations/Clarifications: FBG: fasting blood glucose; positive family history of diabetes: presence of a first or second-degree relative with diabetes; and single-parent family: divorced, separated, or widowed legal guardians. Results are presented as median (interquartile range).
Table
Table 2. Body composition and heart rate variability indices of the two study groups.
Table 2. Body composition and heart rate variability indices of the two study groups.
VariablesEuglycemic Group
IQR
(n = 16)		Prediabetic Group
IQR
(n = 13)		Statistical Significance
Total Body Water
(Body Weight %)		50 (46–58)49 (43.5–53)0.455
Total Body Water
(L)		28.5 (26–36)40.6 (27.25–45.3)0.144
Extracellular Water (Body Weight %)45 (42–47.5)40 (39–46)0.14
Extracellular Water
(L)		13.1 (12.3–15.7)15.9 (12.75–17.5)0.124
Intracellular Water (Body Weight %)55 (52.5–58)60 (54–61)0.14
Intracellular Water
(L)		15.6 (14.1–20.9)24.3 (14.75–27.75)0.124
Fat-Free Mass
(Body Weight %)		72 (68.5–87.5)68 (59.5–81)0.174
Fat-Free Mass
(kg)		44.1 (41.15–52.7)55.5 (43.9–61.85)0.112
Fat Mass
(Body Weight %)		28 (12.5–32)32 (19–40.5)0.174
Fat Mass
(kg)		15.6 (6.55–25.1)28.9 (10.5–38.55)0.112
Skeletal Muscle Mass
(kg)		14.6 (13.1–20.05)23.4 (13.75–26.95)0.124
Skeletal Muscle Mass
(Fat-Free Mass %)		33.1 (31.45–40.15)40.3 (34.55–44.75)0.151
Abdominal Adipose Tissue
(cm2)		231.65 (115.075–437.65)470.25 (119.7–650.48)0.204
Intramuscular Adipose Tissue
(kg)		0.8 (0.6–1.5)1.75 (0.75–2.2)0.108
Intramuscular Adipose Tissue
(Body Weight %)		1.5 (1–1.8)1.95 (1.15–2.35)0.116
Mean Heart Rate76.1 (69.33–78.58)77.3 (74.5–89.5)0.172
SDNN (ms)106 (75.75–201.5)82 (52–117.5)0.238
RMSSD (ms)104 (56–267.25)104 (39–115.5)0.306
Scatter area (ms2)30,852.5 (11,185.75–32,269.5)20,778 (5702.5–36,513)0.239
TOTAL POWER
(ms2/Hz)		9.275 (8.5–9.95)8.7 (7.89–9.195)0.154
VLF POWER
(ms2/Hz)		8.05 (7.46–8.66)7.12 (6.87–7.87)0.107
LF POWER
(ms2/Hz)		7.97 (7.49–8.74)7.14 (6.9–8.51)0.193
HF POWER
(ms2/Hz)		8.335 (7.04–9.2)7.82 (6.51–8.275)0.154
LF/HF
Log		−0.4 (–0.625–0.125)−0.1 (–0.7–0.55)0.619
LF/HF
Ratio		0.7 (0.575–1.25)0.9 (0.5–1.7)0.732
LF %40.4 (35–52.13)47.9 (32.7–63)0.762
HF %59.6 (47.88–65)52.1 (37–67.3)0.762
Abbreviations: SDNN: standard deviation of normal-to-normal intervals; RMSSD: root mean square of successive differences; VLF: very low frequency; LF: low frequency; HF: high frequency; and ms: milliseconds. Results are presented as median (interquartile range).

Share and Cite

MDPI and ACS Style

Stefanaki, C.; Michos, A.; Latsios, G.; Tousoulis, D.; Peppa, M.; Zosi, P.; Boschiero, D.; Bacopoulou, F. Sexual Dimorphism of Heart Rate Variability in Adolescence: A Case-Control Study on Depression, Anxiety, Stress Levels, Body Composition, and Heart Rate Variability in Adolescents with Impaired Fasting Glucose. Int. J. Environ. Res. Public Health 2020, 17, 2688. https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph17082688

AMA Style

Stefanaki C, Michos A, Latsios G, Tousoulis D, Peppa M, Zosi P, Boschiero D, Bacopoulou F. Sexual Dimorphism of Heart Rate Variability in Adolescence: A Case-Control Study on Depression, Anxiety, Stress Levels, Body Composition, and Heart Rate Variability in Adolescents with Impaired Fasting Glucose. International Journal of Environmental Research and Public Health. 2020; 17(8):2688. https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph17082688

Chicago/Turabian Style

Stefanaki, Charikleia, Athanasios Michos, George Latsios, Dimitrios Tousoulis, Melpomeni Peppa, Paraskevi Zosi, Dario Boschiero, and Flora Bacopoulou. 2020. "Sexual Dimorphism of Heart Rate Variability in Adolescence: A Case-Control Study on Depression, Anxiety, Stress Levels, Body Composition, and Heart Rate Variability in Adolescents with Impaired Fasting Glucose" International Journal of Environmental Research and Public Health 17, no. 8: 2688. https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph17082688

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop